drugset
drugset / Trial / NCT00346424

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters

NCT00346424 ↗

Phase 3 Completed 300 enrolled ARCA Biopharma, Inc.
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of the study is to compare the safety and effectiveness of alfimeprase to a placebo in restoring function of occluded central catheters.

Timeline

Start
2005-09
Primary completion
2006-10
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfimeprase Protein / enzyme biologic — —

Indications

thrombotic disease venous thromboembolism